$0.00
0.00% day before yesterday
Nasdaq, Aug 11, 03:30 pm CET
ISIN
US0051111096
Symbol
AFIB

Acutus Medical Inc Stock price

$0.00
-0.00 77.27% 1M
-0.05 98.98% 6M
-0.05 99.09% YTD
-0.03 98.25% 1Y
-1.66 99.97% 3Y
-24.85 100.00% 5Y
-26.50 100.00% 10Y
-26.50 100.00% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.00 0.00%

Key metrics

Basic
Market capitalization
$10.0k
Enterprise Value
$18.6m
Net debt
$18.6m
Cash
$14.0m
Shares outstanding
29.9m
Valuation (TTM | estimate)
P/E
negative | 0.0
P/S
0.0 | 0.0
EV/Sales
0.9 | 0.4
EV/FCF
negative
P/B
0.0
Financial Health
Equity Ratio
-40.5%
Return on Equity
82.4%
ROCE
-58.2%
ROIC
-71.7%
Debt/Equity
-2.8
Financials (TTM | estimate)
Revenue
$20.2m | $50.4m
EBITDA
$-9.1m | $-46.8m
EBIT
$-9.4m | $-55.7m
Net Income
$-9.6m | $-42.7m
Free Cash Flow
$-31.8m
Growth (TTM | estimate)
Revenue
-7.8% | 150.2%
EBITDA
87.6% | -412.8%
EBIT
87.2% | -491.8%
Net Income
84.1% | -347.2%
Free Cash Flow
49.8%
Margin (TTM | estimate)
Gross
5.0%
EBITDA
-45.3% | -92.8%
EBIT
-46.8%
Net
-47.4% | -84.7%
Free Cash Flow
-157.7%
More
EPS
$-0.3
FCF per Share
$-1.1
Short interest
1.9%
Employees
85
Rev per Employee
$240.0k
Show more

Is Acutus Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Acutus Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Acutus Medical Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Acutus Medical Inc forecast:

Hold
50%
Sell
50%

Financial data from Acutus Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20 20
8% 8%
100%
- Direct Costs 19 19
43% 43%
95%
1 1
108% 108%
5%
- Selling and Administrative Expenses 10 10
74% 74%
52%
- Research and Development Expense - -
-
-
-9.14 -9.14
88% 88%
-45%
- Depreciation and Amortization 0.30 0.30
58% 58%
1%
EBIT (Operating Income) EBIT -9.43 -9.43
87% 87%
-47%
Net Profit -9.55 -9.55
84% 84%
-47%

In millions USD.

Don't miss a Thing! We will send you all news about Acutus Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Acutus Medical Inc Stock News

Neutral
GlobeNewsWire
5 months ago
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024.

Company Profile

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.

Head office United States
CEO Takeo Mukai
Employees 85
Founded 2011
Website www.acutusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today